Trade Mark Journal No.2026/026 26 June 2026

WO0000001917800 (5,42,44)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:20 January 2026
Date of designation in the UK: 20 January 2026
Image for mark 1917800_TIF MyDendritte

International priority date claimed: 1 August 2025 (European Union Intellectual Property Office (EUIPO)) (019226676)
Class 5
Cells for medical use in the field of oncology; stem cells for use in the following fields: oncology; cell growth media for growing cells for medical use in the field of oncology; pharmaceutical products for use in the following fields: oncology; para-pharmaceutical products for use in the following fields: oncology; chemical preparations for medical purposes for use in the following fields: oncology; chemical preparations for pharmaceutical purposes for use in the following fields: oncology; medicines for human purposes for use in the following fields: oncology; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; immunotherapy products; pharmaceutical products for genetic therapy.
Class 42
Scientific services relating to the isolation and cultivation of human tissues and cells; research and development for the pharmaceutical industry; research and development in the field of microorganisms and cells; scientific research; chemical research; biological research; biomedical research services; research and development in the field of drug delivery systems; laboratory services; stem cell research.
Class 44
Medical and healthcare services; medical services relating to the removal, treatment and processing of human cells; pharmaceutical services; medical and healthcare clinics; ambulant medical care; medical diagnostic services; health advice and information services; outpatient oncology; charitable services, namely, providing medical services to needy persons; genetic testing for medical purposes; consultancy and information services relating to pharmaceutical products; advisory services relating to medical services; medical analysis services for cancer diagnosis and prognosis; providing on-line information relating to oncology; providing medical support in the monitoring of patients receiving medical treatments; medical laboratory services for the analysis of samples taken from patients; stem cell storage.

Masarykova univerzita

Representative: HARBER IP S.R.O., Dukelských hrdinů 567/52, CZ-170 00 Prague 7 - Holešovice, CZECHIA